Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Diphenylpyrazole-derived compounds increase survival time of mice after prion infection.

Leidel F, Eiden M, Geissen M, Kretzschmar HA, Giese A, Hirschberger T, Tavan P, Schätzl HM, Groschup MH.

Antimicrob Agents Chemother. 2011 Oct;55(10):4774-81. doi: 10.1128/AAC.00151-11. Epub 2011 Jul 11.

PMID:
21746938
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies.

Kocisko DA, Caughey B.

Methods Enzymol. 2006;412:223-34. Review.

PMID:
17046661
[PubMed - indexed for MEDLINE]
3.

New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B.

J Virol. 2003 Oct;77(19):10288-94.

PMID:
12970413
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.

Kocisko DA, Engel AL, Harbuck K, Arnold KM, Olsen EA, Raymond LD, Vilette D, Caughey B.

Neurosci Lett. 2005 Nov 11;388(2):106-11.

PMID:
16039063
[PubMed - indexed for MEDLINE]
5.

Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59).

Cordier C, Bencsik A, Philippe S, Bétemps D, Ronzon F, Calavas D, Crozet C, Baron T.

J Gen Virol. 2006 Dec;87(Pt 12):3763-71.

PMID:
17098996
[PubMed - indexed for MEDLINE]
Free Article
6.

Molecular analysis of the protease-resistant prion protein in scrapie and bovine spongiform encephalopathy transmitted to ovine transgenic and wild-type mice.

Baron T, Crozet C, Biacabe AG, Philippe S, Verchere J, Bencsik A, Madec JY, Calavas D, Samarut J.

J Virol. 2004 Jun;78(12):6243-51.

PMID:
15163717
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease.

Geissen M, Leidel F, Eiden M, Hirschberger T, Fast C, Bertsch U, Tavan P, Giese A, Kretzschmar H, Schatzl HM, Groschup MH.

ChemMedChem. 2011 Oct 4;6(10):1928-37. doi: 10.1002/cmdc.201100119. Epub 2011 Jul 13.

PMID:
21755599
[PubMed - indexed for MEDLINE]
8.

Transgenic models of prion disease.

Scott MR, Supattapone S, Nguyen HO, DeArmond SJ, Prusiner SB.

Arch Virol Suppl. 2000;(16):113-24. Review.

PMID:
11214913
[PubMed - indexed for MEDLINE]
9.

Experimental interspecies transmission studies of the transmissible spongiform encephalopathies to cattle: comparison to bovine spongiform encephalopathy in cattle.

Hamir AN, Kehrli ME Jr, Kunkle RA, Greenlee JJ, Nicholson EM, Richt JA, Miller JM, Cutlip RC.

J Vet Diagn Invest. 2011 May;23(3):407-20. doi: 10.1177/1040638711403404. Review.

PMID:
21908269
[PubMed - indexed for MEDLINE]
Free Article
10.

Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implications for the mechanism of action of polyene antibiotics.

Adjou KT, Demaimay R, Lasmézas CI, Seman M, Deslys JP, Dormont D.

Res Virol. 1996 Jul-Aug;147(4):213-8.

PMID:
8837228
[PubMed - indexed for MEDLINE]
11.

Piperazine derivatives inhibit PrP/PrP(res) propagation in vitro and in vivo.

Leidel F, Eiden M, Geissen M, Hirschberger T, Tavan P, Giese A, Kretzschmar HA, Schätzl H, Groschup MH.

Biochem Biophys Res Commun. 2014 Feb 28;445(1):23-9. doi: 10.1016/j.bbrc.2014.01.122. Epub 2014 Feb 3.

PMID:
24502948
[PubMed - indexed for MEDLINE]
12.
13.

A novel generation of heparan sulfate mimetics for the treatment of prion diseases.

Adjou KT, Simoneau S, Salès N, Lamoury F, Dormont D, Papy-Garcia D, Barritault D, Deslys JP, Lasmézas CI.

J Gen Virol. 2003 Sep;84(Pt 9):2595-603.

PMID:
12917481
[PubMed - indexed for MEDLINE]
Free Article
15.

Tetracyclines affect prion infectivity.

Forloni G, Iussich S, Awan T, Colombo L, Angeretti N, Girola L, Bertani I, Poli G, Caramelli M, Grazia Bruzzone M, Farina L, Limido L, Rossi G, Giaccone G, Ironside JW, Bugiani O, Salmona M, Tagliavini F.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10849-54. Epub 2002 Jul 29.

PMID:
12149459
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Genetic and infectious prion diseases.

Prusiner SB.

Arch Neurol. 1993 Nov;50(11):1129-53. Review.

PMID:
8105771
[PubMed - indexed for MEDLINE]
17.

Differential diagnosis of infections with the bovine spongiform encephalopathy (BSE) and scrapie agents in sheep.

Jeffrey M, Martin S, González L, Ryder SJ, Bellworthy SJ, Jackman R.

J Comp Pathol. 2001 Nov;125(4):271-84.

PMID:
11798244
[PubMed - indexed for MEDLINE]
18.

A C-terminal protease-resistant prion fragment distinguishes ovine "CH1641-like" scrapie from bovine classical and L-Type BSE in ovine transgenic mice.

Baron T, Bencsik A, Vulin J, Biacabe AG, Morignat E, Verchere J, Betemps D.

PLoS Pathog. 2008 Aug 29;4(8):e1000137. doi: 10.1371/journal.ppat.1000137.

PMID:
18769714
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Caramelli M, Ru G, Acutis P, Forloni G.

CNS Drugs. 2006;20(1):15-28. Review.

PMID:
16396521
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk